
Background: Inflammatory bowel disease (IBD) affects > 3 million Americans and often requires expensive care spanning decades. Using national data, we evaluated the association between IBD and patient financial hardship, subgroups most affected, and changes over time. Methods: Using the 2015, 2016, 2023, and 2024 National Health Interview Surveys, we matched adults with IBD to non-IBD controls on age, sex, race, geographic region, income, insurance status, and employment status using coarsened exact matching. Multivariable logistic regression was used to evaluate the association between IBD and 8 measures of financial hardship, as well as changes in hardship over time. Results: Of patients with IBD, 35.2% reported financial hardship in the past year, vs 25.4% of matched controls (odds ratio [OR] 1.71; 95% CI, 1.50-1.96). 12.7% of patients with IBD delayed care due to cost, vs 7.6% of controls (OR, 1.95; 95% CI, 1.63-2.32). Finally, 15.5% of patients with IBD reported cost-related medication nonadherence, vs 8.2% of controls (OR, 2.22; 95% CI, 1.87-2.64). Age < 65 years, living in the South, lower income, and being uninsured were associated with higher odds of financial hardship. From 2015 to 2024, the proportion of patients with IBD reporting problems paying medical bills declined by 5.1% points (pp; 95% CI, -9.8 to -0.4), and cost-related medication nonadherence declined by 5.6 pp (95% CI, -9.9 to -1.3), but other financial hardship measures remained unchanged. Conclusion: Each year, 1 in 3 Americans with IBD experiences financial hardship and 1 in 6 skips medications due to cost, far more than their peers without IBD. Research is needed to identify interventions to reduce financial hardship in IBD. on behalf of Society for Surgery of the Alimentary Tract.